This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Fluctuating DNA methylation tracks cancer evolution at clinical scale
Nature Open Access 10 September 2025
-
The evolution of lung cancer and impact of subclonal selection in TRACERx
Nature Open Access 12 April 2023
-
Immune selection determines tumor antigenicity and influences response to checkpoint inhibitors
Nature Genetics Open Access 09 March 2023
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout


References
Tarabichi, M. et al. Nat. Genet. https://doi.org/10.1038/s41588-018-0258-x (2018).
Williams, M. J., Werner, B., Barnes, C. P., Graham, T. A. & Sottoriva, A. Nat. Genet. 48, 238–244 (2016).
Williams, M. J. et al. Nat. Genet. 50, 895–903 (2018).
Sun, R. et al. Nat. Genet. 49, 1015–1024 (2017).
Wu, C.-I., Wang, H.-Y., Ling, S. & Lu, X. Annu. Rev. Genet. 50, 347–369 (2016).
Durrett, R. Ann. Appl. Probab. 23, 230–250 (2013).
Kessler, D. A. & Levine, H. Proc. Natl. Acad. Sci. USA 110, 11682–11687 (2013).
Kessler, D. A. & Levine, H. J. Stat. Phys. 158, 783–805 (2015).
Bozic, I., Gerold, J. M. & Nowak, M. A. PLOS Comput. Biol. 12, e1004731 (2016).
Temko, D. et al. J. Pathol. 245, 283–296 (2018).
Nik-Zainal, S. et al. Cell 149, 994–1007 (2012).
Martincorena, I. et al. Cell 171, 1–3 (2017).
Martincorena, I. & Campbell, P. J. Science 349, 1483–1489 (2015).
Wang, K. et al. Nat. Genet. 46, 573–582 (2014).
Zapata, L. et al. Genome Biol. 19, 67 (2018).
Acknowledgements
A.S. is supported by the Chris Rokos Fellowship in Evolution and Cancer and by Cancer Research UK (A22909). T.A.G. is supported by Cancer Research UK (A19771). C.P.B. is supported by the Wellcome Trust (097319/Z/11/Z). B.W. is supported by a Geoffrey W. Lewis Post-Doctoral Training fellowship. A.S. and T.A.G. are jointly supported by the Wellcome Trust (202778/B/16/Z and 202778/Z/16/Z, respectively). M.J.W. is supported by a Medical Research Council student scholarship.
Author information
Authors and Affiliations
Contributions
T.H. performed simulation and bioinformatic analyses. L.Z. performed dN/dS analysis. M.J.W. performed additional simulation analysis. B.W. performed mathematical analysis. G.C. provided expertise on clustering analysis. C.P.B., T.A.G. and A.S. conceived and led the study. All authors addressed the criticism and wrote the response.
Corresponding authors
Supplementary information
Supplementary Text and Figures
Supplementary Methods and Supplementary Figures 1 and 2
Supplementary Table 1
Supplementary Table 1
Supplementary Table 2
Supplementary Table 2
Rights and permissions
About this article
Cite this article
Heide, T., Zapata, L., Williams, M.J. et al. Reply to ‘Neutral tumor evolution?’. Nat Genet 50, 1633–1637 (2018). https://doi.org/10.1038/s41588-018-0256-z
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41588-018-0256-z
This article is cited by
-
Fluctuating DNA methylation tracks cancer evolution at clinical scale
Nature (2025)
-
Immune selection determines tumor antigenicity and influences response to checkpoint inhibitors
Nature Genetics (2023)
-
The evolution of lung cancer and impact of subclonal selection in TRACERx
Nature (2023)
-
Population genetics of clonally transmissible cancers
Nature Ecology & Evolution (2022)
-
A practical guide to cancer subclonal reconstruction from DNA sequencing
Nature Methods (2021)